Drug Regulation

FDA Quality Control Counterfeit Drugs FDA Decisions GLP-1 Drugs Fixed Dose Combinations Illegal Drug Trade Market Surveillance FDA Actions Illegal Drugs

3 ARTICLES

4d ago

FDA Advisers Narrowly Back Compounding of Four Popular Peptides

A split vote could let pharmacies legally compound BPC‑157, KPV, TB‑500 and MOTS‑C during a months‑long FDA review of safety data, panel conflicts, public comment

8 ARTICLES

3w ago

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

15 ARTICLES

last mo.

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

6 ARTICLES

2mo ago

Appeals Court Halts Mail Delivery of Abortion Pill Mifepristone Nationwide

3 ARTICLES

3mo ago

Telangana Drug Regulator Flags 75 Pharmacies in GLP-1 Sales Crackdown

8 ARTICLES

3mo ago

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link

13 ARTICLES

3mo ago

India Tightens Oversight of GLP-1 Diabetes and Weight-Loss Drugs

26 ARTICLES

4mo ago

India Tightens Oversight as Low‑Cost Semaglutide Hits Pharmacies

3 ARTICLES

4mo ago

India’s Drug Regulator Flags 90 Unapproved Fixed-Dose Medicines, Orders State Probes

4 ARTICLES

5mo ago

DCA Seizes ₹8 Lakh in Drugs, Uncovers Alleged Label Tampering in NTR District

6 ARTICLES

5mo ago

ANMAT Cancels Authorizations for More Than 60 Drug Distributors Over Expired Certificates

9 ARTICLES

5mo ago

ANMAT Bans Imported Tide Detergent Over Labeling Breaches, Orders Recall and Sanitary Probe

19 ARTICLES

5mo ago

Hims & Hers Halts $49 Compounded Wegovy Pill as FDA Tightens GLP-1 Rules

5 ARTICLES

6mo ago

Cofepris Issues January 20–21 Health Alerts on Counterfeit Entresto and Illegally Sold Products in Mexico

9 ARTICLES

6mo ago

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

14 ARTICLES

6mo ago

Argentina Names Luis Fontana to Lead ANMAT After Fentanyl Scandal

Drug Regulation

FDA Advisers Narrowly Back Compounding of Four Popular Peptides

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

India Bans 16 Fixed‑Dose Combination Drugs

FDA Approves Colorado Plan to Import 20 Prescription Drugs From Canada

Digemid Closes 666 Pharmacies After Nationwide Inspections

India Reclassifies Pregabalin as Schedule H1

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

Appeals Court Halts Mail Delivery of Abortion Pill Mifepristone Nationwide

Telangana Drug Regulator Flags 75 Pharmacies in GLP-1 Sales Crackdown

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link

Never miss stories about

Drug Regulation

India Tightens Oversight of GLP-1 Diabetes and Weight-Loss Drugs

India Tightens Oversight as Low‑Cost Semaglutide Hits Pharmacies

India’s Drug Regulator Flags 90 Unapproved Fixed-Dose Medicines, Orders State Probes

DCA Seizes ₹8 Lakh in Drugs, Uncovers Alleged Label Tampering in NTR District

ANMAT Cancels Authorizations for More Than 60 Drug Distributors Over Expired Certificates

ANMAT Bans Imported Tide Detergent Over Labeling Breaches, Orders Recall and Sanitary Probe

Hims & Hers Halts $49 Compounded Wegovy Pill as FDA Tightens GLP-1 Rules

Cofepris Issues January 20–21 Health Alerts on Counterfeit Entresto and Illegally Sold Products in Mexico

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Argentina Names Luis Fontana to Lead ANMAT After Fentanyl Scandal

Never miss stories about

Drug Regulation